S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Elon Did It Again: This Could be Bigger than Tesla (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Elon Did It Again: This Could be Bigger than Tesla (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Elon Did It Again: This Could be Bigger than Tesla (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Elon Did It Again: This Could be Bigger than Tesla (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Elon Did It Again: This Could be Bigger than Tesla (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
TSE:GUD

Knight Therapeutics (GUD) Earnings Date, Estimates & Call Transcripts

C$4.53
0.00 (0.00%)
(As of 10/3/2023 ET)
Compare
Today's Range
C$4.44
▼
C$4.58
50-Day Range
C$4.37
▼
C$4.85
52-Week Range
C$4.28
▼
C$5.60
Volume
115,081 shs
Average Volume
97,167 shs
Market Capitalization
C$483.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$6.25
ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlinesSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 10)
C$0.02 Missed By -C$0.01
Consensus EPS
(Aug. 10)
C$0.03
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

GUD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GUD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Knight Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate:C($0.07) EPS

GUD Earnings Date and Information

Knight Therapeutics last posted its quarterly earnings results on August 10th, 2023. The reported C$0.02 EPS for the quarter, missing analysts' consensus estimates of C$0.03 by C$0.01. The firm had revenue of C$89.91 million for the quarter, compared to analysts' expectations of C$80.15 million. Knight Therapeutics has generated C($0.14) earnings per share over the last year (C($0.14) diluted earnings per share). Knight Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

Knight Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)		------- 
8/10/2023Q2 2023C$0.03C$0.02C($0.01)C$0.02C$80.15 millionC$89.91 million
5/11/2023Q1 2023-C($0.04)C($0.04)C($0.04)C$74.80 millionC$82.60 million
3/23/2023Q4 2022-C$0.02+C$0.02C$0.17C$62.00 millionC$81.66 million
11/10/2022Q3 2022C($0.01)C$0.02+C$0.03C$0.03C$67.03 millionC$72.28 million
8/11/2022Q2 2022C$0.02C$0.02-C$0.02C$66.27 millionC$75.82 million
5/12/2022Q1 2022C($0.04)C($0.02)+C$0.02C$0.12C$52.80 millionC$63.81 million
3/24/2022Q4 2021-C($0.08)C($0.08)C($0.09)C$61.00 millionC$58.27 million
11/11/2021Q3 2021C$0.03C$0.07+C$0.04C$0.21C$62.00 millionC$73.34 million
5/14/2021Q1 2021C($0.02)C($0.03)C($0.01)C($0.09)C$52.50 millionC$46.07 million
3/25/2021Q4 2020C$0.01C$0.03+C$0.02-C$47.00 millionC$55.19 million
11/13/2020Q3 2020C$0.01C$0.05+C$0.04C($0.04)C$50.45 millionC$45.24 million












Knight Therapeutics Earnings - Frequently Asked Questions

When is Knight Therapeutics's earnings date?

Knight Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on GUD's earnings history.

Did Knight Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Knight Therapeutics (TSE:GUD) missed the analysts' consensus estimate of C$0.03 by C$0.01 with a reported earnings per share (EPS) of C$0.02. Learn more on analysts' earnings estimate vs. GUD's actual earnings.

How much revenue does Knight Therapeutics generate each year?

Knight Therapeutics (TSE:GUD) has a recorded annual revenue of C$326.44 million.

How much profit does Knight Therapeutics generate each year?

Knight Therapeutics (TSE:GUD) has a recorded net income of -C$15.69 million. GUD has generated -C$0.14 earnings per share over the last four quarters.

What is Knight Therapeutics's price-to-earnings ratio?

Knight Therapeutics (TSE:GUD) has a . The price/earnings-to-growth ratio is -1013.5.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (TSE:GUD) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -